Blueshift Asset Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Blueshift Asset Management, LLC

  • $191 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$58.38 - $84.96 $179,868 - $261,761
-3,081 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$62.15 - $90.32 $191,484 - $278,275
3,081 New
3,081 $255,000
Q1 2021

May 06, 2021
SELL
$61.35 - $90.47 $451,290 - $665,497
-7,356 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$43.82 - $85.37 $322,339 - $627,981
7,356 New
7,356 $564,000

Others Institutions Holding ARWR

# of Institutions
296
Shares Held
88.5M
Call Options Held
905K
Put Options Held
387K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.71B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email